Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High-dose Spironolactone in ADHF
NCT02585843Phase 3Completed
- Sponsor
- Columbia University
- Start
- Nov 2015
- Primary completion
- Mar 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of spironolactone in heart failure (HF), sponsored by Columbia University. Started Nov 2015; status: completed.
02
Drugs
spironolactone
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on NCT02585843.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02585843.